FLEX vs OGN · P/E 23, rev $6.40B vs P/E 3.4, rev $6.40B
Flex Ltd (FLEX) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Flex Ltd (FLEX) is a electronic components company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
FLEX currently screens at market cap $18.12B and trailing P/E 23.0. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the FLEX and OGN stock pages for the full models.
Not investment advice.